Recap: Nektar Therapeutics Q2 Earnings

Nektar Therapeutics NKTR reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Nektar Therapeutics beat estimated earnings by 9.57%, reporting an EPS of $-0.85 versus an estimate of $-0.94.

Revenue was down $6.75 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.19 which was followed by a 2.03% drop in the share price the next day.

Here's a look at Nektar Therapeutics's past performance:

To track all earnings releases for Nektar Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.